Yekaterina Chudnovsky
Director/Board Member at ELICIO THERAPEUTICS, INC.
Net worth: 7 M $ as of 2024-04-29
Yekaterina Chudnovsky active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director/Board Member | 2022-09-30 | - |
| Independent Dir/Board Member | 2022-09-30 | - | |
| IMMIX BIOPHARMA, INC. | Director/Board Member | 2023-08-21 | - |
| Independent Dir/Board Member | 2023-08-21 | - | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Director/Board Member | - | - |
| Gkcc LLC | Director/Board Member | - | - |
Career history of Yekaterina Chudnovsky
Training of Yekaterina Chudnovsky
| Northwestern University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Statistics
International
| United States | 8 |
Operational
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ELICIO THERAPEUTICS, INC. | Health Technology |
| IMMIX BIOPHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |
| Gkcc LLC |
